Skip to main content
GCTK
NASDAQ Industrial Applications And Services

Glucotrack Shareholders Approve Reverse Split and Warrant Inducement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.33
Mkt Cap
$3.65M
52W Low
$0.25
52W High
$14.14
52W Position info
32% above low
Off High info
98% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

GCTK sits 32% above its 52-week low of $0.25 on light trading volume (0.1× avg).

Summary

Glucotrack's shareholders approved a reverse stock split up to 1-for-30 and a warrant inducement plan, along with director elections and auditor ratification.


Key Events · Corporate Governance and Compliance · GCTK

  • Reverse Stock Split Approved

    Shareholders approved a reverse stock split at a ratio not to exceed 1-for-30, with 2,099,338 votes for and 674,484 against. The split is intended to address Nasdaq delisting risk.

  • Warrant Inducement Approved

    Shareholders approved a warrant inducement plan, including repricing existing warrants and issuing new inducement warrants, with 895,306 votes for and 138,265 against. This will increase potential dilution.

  • Directors Elected

    All six director nominees were elected, including CEO Erik Emerson, with votes for ranging from 934,050 to 961,363.

  • Say-on-Pay and Auditor Ratified

    Executive compensation was approved on an advisory basis (962,623 for), and CBIZ CPAs P.C. was ratified as the independent auditor for fiscal 2026 (2,621,952 for).


Analysis · GCTK · Industrial Applications And Services

Shareholders approved a reverse stock split of up to 1-for-30 and a warrant inducement plan at the annual meeting. The reverse split is a direct response to Nasdaq delisting risk, and the warrant inducement will likely increase dilution. Both measures are part of the company's ongoing effort to stabilize its capital structure amid a cash crisis and going concern doubt.

How filings like this one have moved

In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GCTK was trading at $0.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $0.25 to $14.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GCTK - Latest Insights

GCTK
Oct 14, 2026, 10:02 AM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $1.05
Real-time Price: $0.744 info
Change: -$0.306 (-29%) info
Market Cap: $738.062K info
GCTK
Oct 13, 2026, 9:45 PM EDT
Filing Type: S-1/A
Importance Score:
8
Price at Filing: $1.11
Real-time Price: $0.744 info
Change: -$0.366 (-33%) info
Market Cap: $738.062K info
GCTK
Sep 28, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $0.744 info
Change: -$1.04 (-58%) info
Market Cap: $738.062K info
GCTK
Sep 24, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $0.744 info
Change: -$1.91 (-72%) info
Market Cap: $738.062K info
GCTK
Sep 24, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $0.744 info
Change: -$1.91 (-72%) info
Market Cap: $738.062K info